News
CHSYF
0.931
NaN%
--
China Medical System Holdings Maintains Stable Share Capital in November 2025
TipRanks · 4d ago
TFI Asset Management Remains a Buy on China Medical System Holdings (CHSYF)
TipRanks · 4d ago
China Medical System’s New Drug Application for Atopic Dermatitis Accepted in China
TipRanks · 10/30 10:57
China Medical System Secures Distribution Rights for Key Ophthalmic Drugs in China
TipRanks · 10/27 09:39
China Medical System’s MG-K10 Receives Approval for COPD Clinical Trials
TipRanks · 09/30 12:51
China Medical System Holdings Maintains Stable Share Capital in September 2025
TipRanks · 09/30 11:48
China Medical announces Phase 3 ruxolitinib trial met primary endpoint
TipRanks · 09/28 21:00
China Medical System’s MG-K10 Receives Phase III Trial Approval for CSU
TipRanks · 09/28 12:07
China Medical System’s CMS-D002 Receives Approval for Uterine Fibroid Trials
TipRanks · 09/26 11:42
China Medical System Reports Positive Phase 3 Trial Results for Ruxolitinib Cream
TipRanks · 09/26 11:41
China Medical System Expands Biopharmaceutical Portfolio with New Collaboration Agreements
TipRanks · 09/22 12:07
Weekly Report: what happened at CHSYF last week (0908-0912)?
Weekly Report · 09/15 09:47
Weekly Report: what happened at CHSYF last week (0901-0905)?
Weekly Report · 09/08 09:48
China Medical System Transitions to Digital Corporate Communications
TipRanks · 09/02 11:12
China Medical System Holdings Adopts Electronic Communication
TipRanks · 09/02 11:12
Weekly Report: what happened at CHSYF last week (0825-0829)?
Weekly Report · 09/01 09:46
China Medical System Maintains Stable Share Capital in August 2025
TipRanks · 09/01 09:43
China Medical System’s Subsidiary Gains Approval for Povorctinib Trials
TipRanks · 08/28 12:57
Weekly Report: what happened at CHSYF last week (0818-0822)?
Weekly Report · 08/25 09:49
China Medical System Holdings (CHSYF) Gets a Buy from CLSA
TipRanks · 08/20 13:35
More
Webull provides a variety of real-time CHSYF stock news. You can receive the latest news about China Medical through multiple platforms. This information may help you make smarter investment decisions.
About CHSYF
China Medical System Holdings Ltd is an investment holding company principally engaged in the production of medicines, as well as marketing, promotion and sales of drugs. The Company's products include Plendil, Ursofalk, Augentropfen Stulln Mono Eye Drops, Hirudoid, Atopic Piel Series and Vmonalisa, among others. Its major marketed products cover the cardio-cerebrovascular, gastroenterology, ophthalmology, dermatology and medical aesthetic fields. The Company distributes its products within domestic market and to overseas markets.